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In spite of exciting new insights into reg-
ulatory mechanisms that modulate the 
aging process, the proximal cause of aging 
remains one of the unsolved big problems 
in biology. An evolutionary analysis of aging 
provides a helpful theoretical framework 
by establishing boundary conditions on 
possible mechanisms of aging. The funda-
mental insight is that the force of natural 
selection diminishes with age (Medawar, 
1952; Comfort, 1956; Williams, 1957). This 
does not preclude senescence (age-related 
decrease in individual fitness) from occur-
ring in natural populations (Nussey et al., 
2012). Senescence can develop because 
some genes have non-separable, but typi-
cally different or opposite, functions in 
reproductive-age and in old individuals 
(antagonistic pleiotropy; Williams, 1957). 
Such genes, selected according to their 
“youthful” function, may thus impose a 
distinct senescent phenotype in old age. 
In general, however, unless a controversial 
formulation of group selection (Nowak 
et al., 2010; Wilson, 2012) is invoked, traits 
that would become manifest only in old 
age cannot evolve. This precludes the evo-
lutionary emergence of aging programs, 
which have been sometimes postulated to 
exist (Goldsmith, 2012; Mitteldorf, 2012) 
in analogy to developmental and other 
biological programs. (By the same token, 
selective pressure that diminishes with age 
would also prevent extreme longevity from 
evolving, if “extreme” denotes a potential 
life span much longer than that imposed 
by extrinsic mortality in a given environ-
ment.) This and other arguments against 
the existence of an aging program have been 
discussed previously (e.g., Zimniak, 2008; 
Kirkwood and Melov, 2011).
The evolutionary perspective sketched 
out above does not specify the mecha-
nisms that underlie aging, but it helps to 
narrow down the possibilities. As already 
discussed, an evolved deterministic aging 
program can be ruled out, perhaps with 
the exception of specific niche situations. 
In the absence of adaptive life-curtailing 
processes driven by a putative aging pro-
gram, we are left with untargeted pro-
aging, destabilizing phenomena which, in 
principle, may range from purely stochastic 
to side-effects of “legitimate” biochemical 
pathways. These destabilizing forces are 
counteracted by evolved, and genetically 
controlled, longevity assurance (or repair/
maintenance) processes. The interplay of 
these countervailing forces determines the 
life span. While I have previously presented 
my detailed interpretation of this model 
(Zimniak, 2008, 2011), its central tenets 
bear repeating: (a) the destabilizing pro-
cesses that drive aging are neither evolved 
nor adaptive; (b) in contrast, longevity 
assurance mechanisms are under genetic 
control; (c) together, these two opposing 
forces determine life span; (d) the aver-
age life span of a species is set by evolv-
ing longevity assurance mechanisms so 
as to optimize reproductive success under 
environmental conditions typical for that 
species.
It is important to stress that the above 
model allows for longevity assurance, and 
thus life span, being acutely regulated at the 
level of an organism via sensory pathways 
such as insulin or mTOR signaling, as long 
as the resulting life expectancy optimizes 
reproductive success under particular 
environmental conditions. In other words, 
reproductively optimal life spans evolved for 
different environmental situations via adap-
tive selection of distinct set points of anti-
aging repair and/or maintenance processes. 
Thus, the model is fully consistent with the 
disposable soma theory (Kirkwood, 2005 
and references therein).
What exactly, in molecular terms, are the 
maintenance mechanisms able to extend 
life? In addition to its intellectual inter-
est, this question has considerable practi-
cal ramifications, including the holy grail 
of prolonging human life. A good way to 
approach this question is to identify first 
the life-curtailing destabilizing factors that 
are the proximal cause of aging. A focus 
on destabilizing factors does not imply 
that longevity assurance is somehow less 
important. As already discussed, both parts 
of the equation are equally significant in 
determining life span. However, longevity 
assurance mechanisms evolved in response 
to destabilizing factors, so defining the latter 
is a good point to start.
Destabilization is often thought of as a 
purely physical or chemical phenomenon, 
epitomized by the infamous (because of its 
incompleteness) comparison of an aging 
organism to a rusting car. Most emphati-
cally, a biological system is subject to all laws 
of physics and will deteriorate just as a car, 
but this is only one of several processes rel-
evant to a living organism. This, however, is 
a topic for another discussion. In the context 
of the present article it is important to note 
that destabilizing factors include, in addi-
tion to physico-chemical, also biological 
processes. These processes did not evolve 
to drive aging, at least in general. However, 
some side-effects of otherwise homeostatic 
biological reactions clearly contribute to 
aging (Zimniak, 2011).
Historically, the first types of reactions 
proposed to destabilize biological systems 
and to cause aging were free radical and 
oxidative processes (Pearl, 1928; Harman, 
1956). As a consequence, even in today’s lit-
erature, molecular damage is often assumed 
to be limited to oxidative damage, and the 
two terms are used interchangeably. This 
is unfortunate because a wide variety of 
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errors, on scales ranging from molecular 
through microscopic to macroscopic, is 
likely to be relevant to aging.
In addition to the already mentioned 
oxidative and free radical damage, possible 
destabilizing factors are thought to include 
entropy-driven loss of organization inevi-
table in any system that is far from ther-
modynamic equilibrium, stochastic events 
inherent in biological processes which 
often involve relatively small numbers of 
molecules, modifications of essential mac-
romolecules by reactive xenobiotics as well 
as by intermediary metabolites, including 
electrophiles derived mostly from lipid 
peroxidation, and protein misfolding and 
aggregation. Because of space limitations, I 
must refer the reader to my previous reviews 
of these topics (Zimniak, 2008, 2011) for 
additional details and references, as well 
as for a discussion of longevity assurance 
mechanisms able to offset the various types 
of damage. Here, I would like to focus on a 
new and radical development in the aging 
field, namely an attempt to falsify the above 
model of aging and to replace it by a new 
paradigm.
In a series of papers (e.g., Blagosklonny, 
2006, 2007a,b, 2008, 2009, 2010a,b, 2011a,b, 
2012; Blagosklonny and Hall, 2009), Mikhail 
Blagosklonny proposed that a novel concep-
tual framework is necessary to understand 
aging. According to the new theory, which 
is gaining acceptance of leading researchers 
in the field (Gems and de la Guardia, 2012), 
aging is driven not by untargeted molecular 
damage, but by hyperfunction and hyper-
trophy secondary to an inappropriate con-
tinuation into adulthood of developmental 
programs, in particular mTOR signaling. 
In this theory, mTOR, which is adaptive 
during growth, would become a quasi-
program with detrimental consequences 
during adulthood, turning the model into 
an example of antagonistic pleiotropy 
(Blagosklonny, 2010b). The failure to termi-
nate the quasi-program in adulthood could 
be attributed to the impossibility of evolving 
an off-switch in the face of a selective pres-
sure that diminishes with age. It should be 
noted that, independently of hyperfunction, 
accumulation of molecular damage would 
still occur, as required by laws of physics 
and chemistry, but such damage would 
be irrelevant to aging because death trig-
gered by hyperfunction-related pathologies 
would precede any life-curtailing effects of 
molecular damage (Blagosklonny, 2012, and 
other works by this author). A schematic 
depiction of the hyperfunction theory is 
shown in Figure 1A, in comparison with the 
molecular damage theory of aging (Figure 
1B). A hypertrophy-based hypothesis has 
been also proposed to explain the replica-
tive life span of yeast (Bilinski and Bartosz, 
2006; Bilinski et al., 2012).
The new perspective provided by the 
hyperfunction theory of aging is attractive 
because of recently identified deficiencies 
of more conventional models, especially 
of the oxidative stress theory. Specifically, 
it has been pointed out that the expected 
correlation between antioxidant status and 
longevity is not consistently observed in 
many experimental settings (e.g., Gems 
and Doonan, 2009; Perez et al., 2009; Pun 
et al., 2009). This may merely reflect the 
need for a more nuanced understanding of 
the chemistry and biology of oxidative stress 
(Gutteridge and Halliwell, 2010; Murphy 
et al., 2011; Halliwell, 2012). In addition, 
the oxidative damage theory may require 
modifications or refinement. For example, 
it has been proposed that oxidative damage 
may limit life span in the wild but not under 
protected laboratory conditions, or that oxi-
dative stress is relevant to health span but 
not to life span (Salmon et al., 2010). The 
hyperfunction theory sidesteps these ques-
tions by declaring all molecular damage to 
be irrelevant to aging. The claim of hyper-
function to exclusivity is, however, worri-
some for several reasons, elaborated below.
As illustrated in Figure 1A, the hyper-
function model postulates a causal chain 
leading from hypertrophy to macroscopic 
pathologies (organ damage) and to death 
(Blagosklonny, 2012). However, I would 
hesitate to accept that catastrophic events, 
such as a stroke in a middle-aged person or 
sepsis in an otherwise healthy individual, 
are aging. Rather, loss of homeostasis, i.e., 
aging, can lower cell/tissue robustness and 
precipitate catastrophic events (Figure 1B). 
If so, the hyperfunction model may be bet-
ter at explaining mortality than aging. This 
may be considered an artificial distinction; 
however, it would be difficult to identify 
catastrophic death events in, for example, 
bacteria, organisms that also age (Rang 
et al., 2011).
Another criticism of the hyperfunc-
tion model may appear trivial. It has been 
claimed that atrophy, a classical sign of 
aging-related decline, can be in fact sec-
ondary to an initial hyperfunction and 
hypertrophy (Blagosklonny, 2012). At the 
Figure 1 | (A) Scheme of the hyperactivity theory of aging (based on Blagosklonny, 2011a; Gems and de 
la Guardia, 2012). (B) Scheme of the molecular damage accumulation theory of aging; asterisks denote 
multiple sources of molecular damage, such as electrophilic stress, oxidative stress, protein misfolding, 
stochastic events, and others. (C) Scheme of a generalized molecular damage accumulation theory of 
aging which includes hyperfunction/hypertrophy as a source of destabilizing molecular damage which acts 
in addition to other sources of damage. See text for more details.
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organ failures. Thus, regardless of its nature, 
molecular damage remains the proximal 
cause of aging (Figure 1C).
The advent of the hyperfunction theory 
of aging has been compared to the replace-
ment of the geocentric with the heliocentric 
worldview (Gems and de la Guardia, 2012). 
Within this rather grand conceptual frame-
work, I may be seen as an old-timer who 
desperately tries to salvage a doomed theory 
by piling up epicycles. Perhaps so – time 
will tell. Meanwhile, I would like to invoke 
another old-timer, William of Ockham. 
Wielding his razor, I propose that, if hyper-
function is treated as a destabilizing process 
that generates molecular damage, all experi-
mental evidence can be accommodated by 
the generalized molecular damage theory of 
aging, without the need to establish a new 
paradigm.
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risk of sounding petty, I would counter 
that with a sufficiently broad definition, 
almost any abnormality could be sub-
sumed under the term hyperfunction. 
In fact, increased ROS production is an 
example of hyperfunction. However, 
the problem goes beyond  semantics and 
touches on mechanism. According to the 
paper quoted above (Blagosklonny, 2012), 
hyperfunction results in hypertrophy and, 
eventually, in cell failure or death, i.e., 
atrophy. But, what is the mechanism of 
this chain of events? Cells and organisms 
are ultimately chemical systems; therefore, 
they are susceptible to chemical (or physi-
cal) interference. In itself, a mere increase 
in the abundance of an overproduced 
component should not matter. However, 
if that component interacts with normal 
cell constituents and interferes with their 
function, it causes damage – molecular 
damage – which may kill the cell. For 
example, an overproduced ligand may over 
stimulate or desensitize a receptor, and an 
overabundant protein may aggregate and 
interfere with intracellular trafficking, or 
co-precipitate with and thus withdraw 
essential cell constituents. Macroscopic 
hypertrophy can have molecular seque-
lae as well; for example, obesity results 
in a pro-inflammatory and pro-oxidant 
state (Grimsrud et al., 2007; Holguin and 
Fitzpatrick, 2010). From this point of view, 
hyperfunction is one of several sources of 
molecular damage, on equal footing with 
reactive metabolites, toxicants, ROS, elec-
trophiles, stochastic events, and many oth-
ers (Figure 1C).
Whereas aging is likely to have multi-
ple contributing causes (Zimniak, 2008; 
Gladyshev, 2012), one of the looming ques-
tions in gerontology is whether any one type 
of damage predominates, and if so, which. 
This question is as important as it is difficult 
to answer, in part because many seemingly 
distinct experimental interventions lead to 
overlapping or identical molecular pertur-
bations of a biological system. Among the 
contenders, oxidative damage has lost much 
of its appeal, perhaps prematurely, whereas 
protein misfolding/aggregation is gaining 
support (Morimoto and Cuervo, 2009; 
Morimoto et al., 2011). Even if hyperfunc-
tion turns out to be the predominant driver 
of aging, I propose that it does so by causing 
molecular damage, rather than by killing 
organisms through triggering catastrophic 
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